We shown that, in contrast to classical opioid receptors, ACKR3 will not trigger classical G protein signaling and is not modulated from the classical prescription or analgesic opioids, including morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists including naloxone. Instead, we set up that LIH383, an ACKR3-selective subnanomolar https://johns617gwl1.wikiparticularization.com/user